Shareholders Approve Massive Increase in Authorized Shares, Paving Way for Significant Future Dilution

summarizeSummary

InflaRx N.V. shareholders approved a substantial increase in authorized share capital and extended the board's authority to issue new shares, indicating a high potential for future dilution.

check_boxKey Events

• Authorized Capital Significantly Increased

  Shareholders approved an immediate increase in authorized share capital to EUR 43.375 million, comprising 180.73 million ordinary and 180.73 million preferred shares, each with a nominal value of EUR 0.12.

• Conditional Future Capital Expansion Approved

  A new article was added to the articles of association, which will automatically increase authorized capital to EUR 91.375 million (380.73 million ordinary and 380.73 million preferred shares) once the aggregate nominal value of issued ordinary shares reaches EUR 18.275 million.

• Broad Share Issuance Authority Extended

  The board's authorization to issue shares and grant subscription rights was extended, along with the power to limit or exclude pre-emption rights, facilitating future capital raises without requiring further shareholder approval for each issuance.

• New Long-Term Incentive Plan Approved

  A new Long-Term Incentive Plan (LTIP 2026) was approved by shareholders, which could lead to further dilution through equity awards to employees and directors.

auto_awesomeAnalysis

The Annual General Meeting results reveal a significant change to InflaRx's capital structure. Shareholders approved an immediate increase in authorized share capital, and critically, a transitional provision that will *automatically* further increase authorized shares if a certain threshold of issued shares is met. This grants the board extensive authority to issue new shares and exclude pre-emption rights, which could lead to substantial dilution for existing shareholders. While the company also received authorization for share repurchases, the overwhelming potential for new share issuance suggests a focus on capital raising. Investors should monitor future capital raise announcements closely, as the company now has the structural capacity for highly dilutive offerings.